le taupatie: basi biologiche ed inquadramento clinico - Limpe

BIBLIOGRAFIA[1] Wenning GK, Jellinger KA.The role of a-synuclein and tau in neurodegenerative movement disordersCurr Opin Neurol 2005;18:357–362.[2] Galpern WR, Lang AE.Interface between tauopathies and synucleinopathies: a tale of two proteins.Ann Neurol 2006;59:449-458.[3] Goedert M.Tau protein and neurodegeneration.Semin Cell Dev Biol 2004;15:45-49.[4] Spillantini MG, Murrell JR, Goedert M, et al.Mutation in the tau gene in familial multiple system tauopathywith presenile dementia.Proc Natl Acad Sci 1998;95:7737-7741.[5] Williams DR.Tauopathies: classification and clinical update on neurodegenerative diseasesassociated with microtubule-associated protein tau.Internal Med J 2006;36 :652-660.[6] Murray B, Lynch T, Farrell M.Clinicopathological features of the tauopathies.Biochem Soc Trans 2005;33:595-599.[7] Knibb JA, Kipps CM, Hodges JR.Frontotemporal dementia.Curr Opin Neurol 2006;19:565-571.[8] Hutton M, Lendon CL, Rizzu P, et al.Association of missense and 5¢-splice-site mutationsin tau with the inherited dementia FTDP-17.Nature 1998;393:702-705.[9] Steele JC, Richardson JC, Olszewski J.Progressive supranuclear palsy. A heterogeneous degeneration involvingthe brainstem, basal ganglia and cerebellum with vertical supranuclear gazeand pseudobulbar palsy, nuchal dystonia and dementia.Arch Neurol 1964;10:333-359.[10] Schrag A, Ben-Shlomo Y, Quinn NP.Prevalence of progressive supranuclear palsy and multiple system atrophy:a cross-sectiona study.Lancet 1999;354:17671-1775.[11] Williams DR, de Silva R, Paviour DC et al.Characteristics of two distinct clinical phenotypes in pathologically provenprogressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism.Brain 2005;128:1247-1258.